2011
DOI: 10.4161/cc.10.22.18043
|View full text |Cite
|
Sign up to set email alerts
|

Nuclear import of a lipid-modified transcription factor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
0

Year Published

2013
2013
2018
2018

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 32 publications
(22 citation statements)
references
References 51 publications
0
22
0
Order By: Relevance
“…According to the aforementioned findings, the abundance of κ-actin was significantly increased in biomechanically stimulated VSMCs (Figures 3A,B ). As earlier results suggested that NFAT5 activity is regulated by stretch-dependent palmitoylation (Eisenhaber et al, 2011 ; Scherer et al, 2014 ) we assumed that the class of carnitine palmitoyl transferases is crucial for the palmitoylation process and thus NFAT5 activity and κ-actin expression. We scrutinized this hypothesis by investigating stretch-induced nuclear translocation of NFAT5 in VSMCs which were treated with etomoxir—an inhibitor of the mitochondrial carnitine palmitoyltransferase 1 that is tested in clinical trials for its capacity to treat congestive heart failure (Holubarsch et al, 2007 ).…”
Section: Resultsmentioning
confidence: 80%
See 1 more Smart Citation
“…According to the aforementioned findings, the abundance of κ-actin was significantly increased in biomechanically stimulated VSMCs (Figures 3A,B ). As earlier results suggested that NFAT5 activity is regulated by stretch-dependent palmitoylation (Eisenhaber et al, 2011 ; Scherer et al, 2014 ) we assumed that the class of carnitine palmitoyl transferases is crucial for the palmitoylation process and thus NFAT5 activity and κ-actin expression. We scrutinized this hypothesis by investigating stretch-induced nuclear translocation of NFAT5 in VSMCs which were treated with etomoxir—an inhibitor of the mitochondrial carnitine palmitoyltransferase 1 that is tested in clinical trials for its capacity to treat congestive heart failure (Holubarsch et al, 2007 ).…”
Section: Resultsmentioning
confidence: 80%
“…However, its palmitoylation appears to be crucial for the stretch-induced nuclear translocation—a covalent attachment of fatty acids to cysteine, sometimes serine and threonine residues of the protein core. Such a modification has been reported to regulate the entry of NFAT5 into the nucleus in response to osmotic stress (Eisenhaber et al, 2011 ). Additionally, our study suggests that the activity of type 1 carnitine palmitoyl transferases (CPT1) is rate-limiting for the translocation process occurring in VSMCs upon exposure to biomechanical stretch.…”
Section: Discussionmentioning
confidence: 99%
“…This study showed that the shortest isoform of NFAT5 (isoform a, which does not contain NES) is anchored to the plasma membrane via myristoylation and palmitoylation at the second (Gly2) and fifth (Cys5) residue of the protein respectively under a resting state, but that it undergoes nuclear import upon hypertonic induction [72]. How this NFAT5 isoform is detached from the plasma membrane upon hypertonic stress remains unknown, but it might represent an alternative mechanism to limit the nuclear import of this NES-deficient NFAT5 isoform to prevent aberrant gene transcription.…”
Section: Regulation Of Nuclear Abundancementioning
confidence: 99%
“…IV) Finally, it is important to note that SIRT6 may directly induce several post translational modifications including deacetylation and/or depalmitoylation on NFAT5 for upregulation of AR [ 12 ]. One intriguing example would be the case of depalmitoylation of NFAT5, which resulted in its nuclear translocation [ 44 ]. Since hydrolysis of long chain fatty acids by SIRT6 was suggested to increase its deacetylase activity and deacetylation has been suggested to activate NFAT5, SIRT6 may also be considered as direct factor regulating NFAT5 and AR [ 9 , 12 ].…”
Section: Discussionmentioning
confidence: 99%